News & Updates
Filter by Specialty:
Survodutide safe to use in cirrhosis patients
Treatment with survodutide, which has previously shown its efficacy in reducing body weight and glycaemia in people with obesity or type 2 diabetes, is well tolerated by patients with compensated or decompensated cirrhosis, reports a study.
Survodutide safe to use in cirrhosis patients
27 Oct 2024
Semaglutide helps prevent HF events, CV death in diabetic patients with CKD
Treatment with semaglutide can significantly lower the risk of time to first heart failure (HF) events or cardiovascular (CV) death in type 2 diabetes (T2D) patients with chronic kidney disease (CKD), a recent study has shown.
Semaglutide helps prevent HF events, CV death in diabetic patients with CKD
24 Oct 2024
Optimal glycaemic control reduces risk of HCC and liver-related mortality in patients with DM
A population-based study of 146,430 Hong Kong patients with diabetes mellitus (DM) reports that optimal vs suboptimal glycaemic control is associated with reduced risk of developing hepatocellular carcinoma (HCC) and liver-related mortality.
Optimal glycaemic control reduces risk of HCC and liver-related mortality in patients with DM
24 Oct 2024
Group intervention may prevent maternal obesity transmission
A group prenatal care intervention appears beneficial in addressing several factors associated with intergenerational transmission of obesity, suggests a study in American Samoa.
Group intervention may prevent maternal obesity transmission
17 Oct 2024
Nationwide exercise programs a cost-effective way to improve public health in SG
Nationwide exercise programs can significantly reduce healthcare costs in Singapore by preventing diabetes, hypertension, and associated mortality, as suggested in a cost-utility analysis.